Order Article Reprints

Weber WC, Streblow ZJ, Kreklywich CN, Denton M, Sulgey G, Streblow MM, Marcano D, Flores PN, Rodriguez-Santiago RM, Alvarado LI, et al. The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ^®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection. Vaccines. 2024; 12(8):893. https://doi.org/10.3390/vaccines12080893

Weber, Whitney C., Zachary J. Streblow, Craig N. Kreklywich, Michael Denton, Gauthami Sulgey, Magdalene M. Streblow, Dorca Marcano, Paola N. Flores, Rachel M. Rodriguez-Santiago, Luisa I. Alvarado, and et al. 2024. "The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ^®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection" Vaccines 12, no. 8: 893. https://doi.org/10.3390/vaccines12080893

Weber, W. C., Streblow, Z. J., Kreklywich, C. N., Denton, M., Sulgey, G., Streblow, M. M., Marcano, D., Flores, P. N., Rodriguez-Santiago, R. M., Alvarado, L. I., Rivera-Amill, V., Messer, W. B., Hochreiter, R., Kosulin, K., Dubischar, K., Buerger, V., & Streblow, D. N. (2024). The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ^®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection. Vaccines, 12(8), 893. https://doi.org/10.3390/vaccines12080893